Control of Japanese Encephalitis--Within Our Grasp?
NEJM 355:869-871, Solomon,T., 2006
Effect of Single Dose of SA 14-14-2 Vaccine 1 Year After Immunisation in Nepalese Children with Japanese Encephalitis: A Case-Control Study
Lancet 366:1375-1378,1335, Ohrr,H.,et al, 2005
Monkeypox-Associated Central Nervous System Disease:A Case Series and Review
Ann Neurol 93:893-905, Money,K.M.,et al, 2023
Acute Viral Encephalitis
NEJM 379:357-366, Tyler,K.L., 2018
Enterovirus Vaccines for an Emerging Cause of Brain-Stem Encephalitis
NEJM 370:792-794, McMinn, P.C., 2014
Clinicopathologic Conference, Rabies Encephalitis
NEJM 368:172-180, Case 1-2013, 2013
The 2012 West Nile Encephalitis Epidemic in Dallas, Texas
JAMA 310:297-307,267, Chung, W.M.,et al, 2013
West Nile Virus: Review of the Literature
JAMA 310:308-315,267, Petersen, L.R.,et al, 2013
Analysis of Relapses in Anti-NMDAR Encephalitis
Neurol 77:996-999, Gabilondo, I.,et al, 2011
Narcolepsy Onset is Seasonal and Increased following the 2009 H1N1 Pandemic in China
Ann Neurol 70:410-417,A5, Han, F.,et al, 2011
Changes in the Incidence and Predictors of Human Immunodeficiency Virus-Associated Dementia in the Era of Highly Active Antiretroviral Therapy
Ann Neurol 63:213-221, Bhaskaran,K.,et al, 2008
Tick-Borne Encephalitis
Lancet 371:1861-1871, Lindquist,L. &Vapalahti,O., 2008
Rabies Encephalomyelitis
Arch Neurol 62:873-882,855, Burton,E.C.,et al, 2005
West Nile Virus Among Blood Donors in the United States, 2003 and 2004
NEJM 353:451-459,516, Stramer,S.L.,et al, 2005
West Nile Virus Infection in the United States
Arch Neurol 61:1190-1195, Tyler,K.L., 2004
West Nile Encephalitis
BMJ 326:865-869, Solomon,T.,et al, 2003
Clinicopath Conf., West Nile Virus Meningoencephalitis
NEJM 348:2239-2247, Case17-2003, 2003
Encephalitis Complicating Smallpox Vaccination
Arch Neurol 60:925-928, Miravalle,A. &Roos,K.L., 2003
Neurologic Manifestations and Outcome of West Nile Virus Infection
JAMA 290:511-515,524,558, Sejvar,J.J.,et al, 2003
West Nile Virus: A Primer for the Clinician
Ann Int Med 137:173-179, Petersen,L.R. &Marfin,A.A., 2002
HIV-associated Neurologic Disease Incidence Changes: Multicenter AIDS Cohort Study, 1990-1998
Neurol 56:257-260, Sacktor,N.,et al, 2001
Neurologic Complications of the Reactivation of Varicella-Zoster Virus
NEJM 342:635-645, Gilden,D.H.,et al, 2000
Incidence and Prevalence of Neurological Disorders Associated with HIV Since the Introduction of Highly Active Antiretroviral Therapy (HAART)
JNNP 69:376-380, Maschke,M. et al, 2000
AIDS-Related Focal Brain Lesions in the Era of Highly Active Antiretroviral Therapy
Neurol 55:1194-1200, Ammassari,A.,et al, 2000
Emerging Arboviral Encephalitis
BJM 321:1484-1485, Solomon,T., &Cardosa,M.J., 2000
Progression of Ischaemic Stroke and Excitotoxic Aminoacids
Lancet 349:79-83, Castillo,J.,et al, 1997
Neuro-Ophthalmic Manifestations of Lyme Disease
J Neuro-Ophthalmol 17:108-121, Balcer,L.J.,et al, 1997
1997 USPHS/IDSA Guidelines for Prevention of Opportunistic Infections in Persons Infected with Human Immunodeficiency Virus
Ann Int Med 127:923-946, , 1997
USPHS/IDSA Guidelines for the Prevention of Opportunistic Infections in Persons Infected with HIV:A Summary
Ann Int Med 124:349-361, 3421996., , 1996
Twice-Weekly Mainten Therapy with Sulfadiazine-Pyrimethamine to Prevent Recurr Toxo Enceph in AIDS Pts
Ann Int Med 123:175-180, Podzamczer,D.,et al, 1995
Prophylactic Neuroprotection for Cerebral Ischemia
Stroke 25:1075-1080, Fisher,M.,et al, 1994
Low-Dose Trimethoprim-Sulfamethoxazole Prophylaxis for Toxoplasmic Encephalitis in Patients with AIDS
Ann Int Med 117:106-111, 163-1641992., Carr,A.,et al, 1992